Dexamethasone inhibits TGF-β2-induced migration of human lens epithelial cells: Implications for posterior capsule opacification prevention

Molecular Medicine Reports

Volumn 5, Issue 6, 2012, Pages 1509-1513

  Yao, Jin ^a   Yang, Wen ^a   Liu, Yuan ^a   Sun, Yan Xi ^a   Jiang, Qin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Dexamethasone; Human lens epithelial cell migration; Matrix metalloproteinases; Mitogen activated protein kinase; Transforming growth factor 2

Indexed keywords

DEXAMETHASONE; GELATIN; GELATINASE A; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CATARACT; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; LENS EPITHELIUM; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ZYMOGRAPHY;

CAPSULE OPACIFICATION; CELL LINE; CELL MOVEMENT; DEXAMETHASONE; ENZYME INHIBITORS; EPITHELIAL CELLS; HUMANS; LENS, CRYSTALLINE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA2; UP-REGULATION;

EID: 84860716906     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.827     Document Type: Article

References (22)

1. Hellawell GO, Ho K, Halliwell M, et al: Long-term outcomes and morbidity after I125 brachytherapy for localised prostate cancer: an early UK series. Clin Oncol 17: 68-69, 2005. (Pubitemid 40090200)
2. Awasthi N, Guo S and Wagner BJ: Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol 127: 555-562, 2009.
3. Awasthi N, Wang-Su ST and Wagner BJ: Downregulation of MMP-2 and -9 by proteasome inhibition: a possible mechanism to decrease LEC migration and prevent posterior capsular opaci- fication. Invest Ophthalmol Vis Sci 49: 1998-2003, 2008.
4. Awasthi N and Wagner BJ: Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification. Invest Ophthalmol Vis Sci 47: 4482-4489, 2006. (Pubitemid 46579376)
5. Wormstone IM, Anderson IK, Eldred JA, Dawes LJ and Duncan G: Short-term exposure to transforming growth factor beta induces long-term fibrotic responses. Exp Eye Res 83: 1238-1245, 2006. (Pubitemid 44397044)
6. Wormstone IM, Wang L and Liu CS: Posterior capsule opacification. Exp Eye Res 88: 257-269, 2009.
7. Hodge WG: Posterior capsule opacification after cataract surgery. Ophthalmology 105: 943-944, 1998.
8. Wormstone IM, Tamiya S, Anderson I and Duncan G: TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci 43: 2301-2308, 2002. (Pubitemid 34700662)
9. Wormstone IM: Posterior capsule opacification: a cell biological perspective. Exp Eye Res 74: 337-347, 2002.
10. Yao K, Tan J, Ye P, et al: Integrin beta1-mediated signaling is involved in transforming growth factor-beta2-promoted migration in human lens epithelial cells. Mol Vis 13: 1769-1776, 2007. (Pubitemid 47496779)
11. Wong TT, Daniels JT, Crowston JG and Khaw PT: MMP inhibition prevents human lens epithelial cell migration and contraction of the lens capsule. Br J Ophthalmol 88: 868-872, 2004. (Pubitemid 38869544)
12. Kimoto K, Nakatsuka K, Matsuo N and Yoshioka H: p38 MAPK mediates the expression of type I collagen induced by TGF-beta 2 in human retinal pigment epithelial cells ARPE-19. Invest Ophthalmol Vis Sci 45: 2431-2437, 2004. (Pubitemid 38902619)
13. Kim D, Dan HC, Park S, et al: AKT/PKB signaling mechanisms in cancer and chemoresistance. Front Biosci 10: 975-987, 2005.
14. Saika S, Yamanaka O, Ikeda K, et al: Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells. Lab Invest 85: 838-850, 2005. (Pubitemid 41021293)
15. Walker TD: Pharmacological attempts to reduce posterior capsule opacification after cataract surgery - a review. Clin Exp Ophthalmol 36: 883-890, 2008.
16. McDonnell PJ, Krause W and Glaser BM: In vitro inhibition of lens epithelial cell proliferation and migration. Ophthalmic Surg 19: 25-30, 1988.
17. Inan UU, Ozturk F, Kaynak S, et al: Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents. J Cataract Refract Surg 27: 1079-1087, 2001. (Pubitemid 32734159)
18. Symonds JG, Lovicu FJ and Chamberlain CG: Differing effects of dexamethasone and diclofenac on posterior capsule opacification-like changes in a rat lens explant model. Exp Eye Res 83: 771-782, 2006. (Pubitemid 44292674)
19. Zaczek A, Laurell CG and Zetterstrom C: Posterior capsule opacification after phacoemulsification in patients with postoperative steroidal and nonsteroidal treatment. J Cataract Refract Surg 30: 316-320, 2004. (Pubitemid 38366354)
20. Maziere C, Conte MA, Leborgne L, et al: UVA radiation stimulates ceramide production: relationship to oxidative stress and potential role in ERK, JNK, and p38 activation. Biochem Biophys Res Commun 281: 289-294, 2001. (Pubitemid 32928151)
21. Sugita M, Kato S, Sugita G and Oshika T: Migration of lens epithelial cells through haptic root of single-piece acrylicfoldable intraocular lens. Am J Ophthalmol 137: 377-379, 2004. (Pubitemid 38221027)
22. Jiang Q, Zhou C, Bi Z and Wan Y: EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells. J Ocul Pharmacol Ther 22: 93-102, 2006. (Pubitemid 43742945)